Farms.com Home   News

Avian Bird Flu Continues To Raise Concerns In Midwest

With the H5N1 avian flu strain sweeping the country, zoos are keeping their birds indoors. In Ohio, a backyard flock was infected, as were a few fowl in northwest Ohio. As a whole, numbers have remained low in the state and no cases were reported in April, according to the U.S. Department of Agriculture.

The Division of Wildlife is working closely with the Ohio Department of Agriculture, USDA, and other state and federal agencies to monitor the Highly Pathogenic Avian Influenza. It is a serious disease and requires rapid response because it is highly contagious and often fatal to chickens.

All Ohioans can report sick or dead wild birds suspected of HPAI at 800-WILDLIFE (945-3543) or wildohio.gov. The following bird species should be reported:

  • Any raptor, such as a bald eagle.
  • Multiple waterfowl, such as geese or ducks.
  • Any other large congregation of sick or dead birds.

HPAI occurs naturally in bird populations and is monitored closely by the U.S. Geological Survey. Native Ohio birds such as shorebirds, raptors and waterfowl are vulnerable to HPAI. Domestic chickens and turkeys also are vulnerable to HPAI. The virus is transmitted from bird to bird through feeding and interactions.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.